Observing recovery characteristics after procedure in patients who are given magnesium sulphate into venous blood while undergoing planned elective surgery under controlled loss of consciousness

Recovery characteristics after intravenous magnesium sulphate in adults undergoing elective surgery under general anaesthesia with endotracheal intubation

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2023/05/052222

Enrollment

128

Registered

2023-05-02

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing elective surgery under general anaesthesia with endotracheal intubation

Exclusion criteria

Exclusion criteria: Pregnant women,children,Patients involved in other studies,Renal disease,Liver disease,Neuromuscular disease,Patients with difficult intubation and anticipated difficult extubation

Design outcomes

Primary

Measure	Time frame
To compare the time of discharge from post anaesthesia care unit(PACU) between patients who are administered intravenous magnesium sulphate and those who are not, during elective surgery under general anaesthesia with endotracheal intubationTimepoint: Vital signs(HR,SBP,DBP,MAP,RR,SpO2) Upon entry into PACU every 10 min till 30 min every 15 min thereafter; Numerical pain rating scale Upon entry into PACU and every 15 min; Richmond Agitation and Sedation Scale Upon entry into PACU and every 15 min; Modified Aldrete Score Upon entry into PACU and every 5 min	—

Measure

Time frame

To compare the time of discharge from post anaesthesia care unit(PACU) between patients who are administered intravenous magnesium sulphate and those who are not, during elective surgery under general anaesthesia with endotracheal intubationTimepoint: Vital signs(HR,SBP,DBP,MAP,RR,SpO2) Upon entry into PACU every 10 min till 30 min every 15 min thereafter; Numerical pain rating scale Upon entry into PACU and every 15 min; Richmond Agitation and Sedation Scale Upon entry into PACU and every 15 min; Modified Aldrete Score Upon entry into PACU and every 5 min

—

Secondary

Measure	Time frame
To observe the clinical recovery characteristics in patients receiving intraoperative intravenous magnesium sulphateTimepoint: Assessment begins after the discontinuing of volatile agents.The patient will then be assessed for HR, SBP, DBP, MAP, SpO2 and spontaneous RR from the point of discontinuing volatile agents till extubation at an interval of 2 minutes; Following extubation, vital signs will be assessed for the next 4 minutes (2 minutes interval)	—

Measure

Time frame

To observe the clinical recovery characteristics in patients receiving intraoperative intravenous magnesium sulphateTimepoint: Assessment begins after the discontinuing of volatile agents.The patient will then be assessed for HR, SBP, DBP, MAP, SpO2 and spontaneous RR from the point of discontinuing volatile agents till extubation at an interval of 2 minutes; Following extubation, vital signs will be assessed for the next 4 minutes (2 minutes interval)

—

Countries

India

Contacts

Public ContactNisha Sara Mundappallil Jacob

Kasturba hospital,Manipal

nishasara@gmail.com9500574751

Outcome results